Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

206.28
+0.31950.16%
Volume:188.52K
Turnover:38.81M
Market Cap:10.47B
PE:32.68
High:206.99
Open:206.88
Low:205.12
Close:205.96
52wk High:217.12
52wk Low:147.95
Shares:50.75M
Float Shares:50.75M
Volume Ratio:1.22
T/O Rate:0.37%
Dividend:0.34
Dividend Rate:0.16%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.29
PE(LYR):5.84

Loading ...

Exchange-Traded Funds, US Equities Decline After Midday

MT Newswires Live
·
Sep 24

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

TradingKey
·
Sep 23

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday as Traders Await Developments in US-Iran Talks

MT Newswires Live
·
Sep 23

Sector Update: Healthcare

MT Newswires Live
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

TIPRANKS
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 23

Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II

TIPRANKS
·
Sep 23

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Dow Jones
·
Sep 23

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS
·
Sep 23

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 23

Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales

Reuters
·
Sep 23

Exchange-Traded Funds Rise, US Equities Mixed After Midday

MT Newswires Live
·
Sep 23

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

Dow Jones
·
Sep 23

New precision medicine venture gives Syngenis added firepower

The West Australian
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

TIPRANKS
·
Sep 22

Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement

TradingKey
·
Sep 22

Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi

TIPRANKS
·
Sep 22

Truist sees ‘significant positive readthrough’ for Maze from Vertex data

TIPRANKS
·
Sep 22

Maze jumps 25% to $27.99 after Vertex kidney disease data

TIPRANKS
·
Sep 22

Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal

Reuters
·
Sep 22